{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:51:18Z","timestamp":1794379878862,"version":"4.9.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54732-x","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:31:42Z","timestamp":1732786302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type\u00a0I interferon and inflammasome activation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-4536","authenticated-orcid":false,"given":"Javier","family":"Rodr\u00edguez-Ubreva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-8221","authenticated-orcid":false,"given":"Josep","family":"Calafell-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia L.","family":"Calvillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baerbel","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ciudad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Fran\u00e7ois","family":"Handfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-3069","authenticated-orcid":false,"given":"Carlos","family":"de la Calle-Fabregat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-5794","authenticated-orcid":false,"given":"Gerard","family":"Godoy-Tena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0621-9914","authenticated-orcid":false,"given":"Eduardo","family":"Andr\u00e9s-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Hoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6063-0659","authenticated-orcid":false,"given":"Tarryn","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8870-0316","authenticated-orcid":false,"given":"Elena","family":"Prigmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-8833","authenticated-orcid":false,"given":"Maike","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annegrit","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2202-0622","authenticated-orcid":false,"given":"Javier","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-8474","authenticated-orcid":false,"given":"Roser","family":"Vento-Tormo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-865X","authenticated-orcid":false,"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1400-2440","authenticated-orcid":false,"given":"Esteban","family":"Ballestar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"54732_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10238-020-00648-x","volume":"20","author":"M Gavriatopoulou","year":"2020","unstructured":"Gavriatopoulou, M. et al. Organ-specific manifestations of COVID-19 infection. Clin. Exp. Med. 20, 493\u2013506 (2020).","journal-title":"Clin. Exp. Med."},{"key":"54732_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru, S. & Merad, M. Pathological sequelae of long-haul COVID. Nat. Immunol. 23, 194\u2013202 (2022).","journal-title":"Nat. Immunol."},{"key":"54732_CR3","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","volume":"34","author":"AT Tan","year":"2021","unstructured":"Tan, A. T. et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep. 34, 108728 (2021).","journal-title":"Cell Rep."},{"key":"54732_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","volume":"587","author":"J Braun","year":"2020","unstructured":"Braun, J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 587, 270\u2013274 (2020).","journal-title":"Nature"},{"key":"54732_CR5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996\u20131012.e19 (2020).","journal-title":"Cell"},{"key":"54732_CR6","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336\u20131345 (2020).","journal-title":"Nat. Immunol."},{"key":"54732_CR7","doi-asserted-by":"publisher","first-page":"eabf8891","DOI":"10.1126\/sciimmunol.abf8891","volume":"5","author":"GE Hartley","year":"2020","unstructured":"Hartley, G. E. et al. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence. Sci. Immunol. 5, eabf8891 (2020).","journal-title":"Sci. Immunol."},{"key":"54732_CR8","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","volume":"386","author":"MJ Levin","year":"2022","unstructured":"Levin, M. J. et al. Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for prevention of Covid-19. N. Engl. J. Med. 386, 2188\u20132200 (2022).","journal-title":"N. Engl. J. Med."},{"key":"54732_CR9","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1056\/NEJMoa2109682","volume":"385","author":"MP O\u2019Brien","year":"2021","unstructured":"O\u2019Brien, M. P. et al. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N. Engl. J. Med. 385, 1184\u20131195 (2021).","journal-title":"N. Engl. J. Med."},{"key":"54732_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa2029849","volume":"384","author":"P Chen","year":"2021","unstructured":"Chen, P. et al. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N. Engl. J. Med. 384, 229\u2013237 (2021).","journal-title":"N. Engl. J. Med."},{"key":"54732_CR11","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","volume":"385","author":"M Dougan","year":"2021","unstructured":"Dougan, M. et al. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19. N. Engl. J. Med. 385, 1382\u20131392 (2021).","journal-title":"N. Engl. J. Med."},{"key":"54732_CR12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","volume":"182","author":"J Schulte-Schrepping","year":"2020","unstructured":"Schulte-Schrepping, J. et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 182, 1419\u20131440.e23 (2020).","journal-title":"Cell"},{"key":"54732_CR13","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","volume":"184","author":"JL Schultze","year":"2021","unstructured":"Schultze, J. L. & Aschenbrenner, A. C. COVID-19 and the human innate immune system. Cell 184, 1671\u20131692 (2021).","journal-title":"Cell"},{"key":"54732_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette, A. & Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184, 861\u2013880 (2021).","journal-title":"Cell"},{"key":"54732_CR15","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).","journal-title":"Science"},{"key":"54732_CR16","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1016\/j.jaip.2021.04.017","volume":"9","author":"C Milito","year":"2021","unstructured":"Milito, C. et al. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J. Allergy Clin. Immunol. Pract. 9, 2904\u20132906.e2 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"54732_CR17","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel, M. G. et al. The European Society for Immunodeficiencies (ESID) Registry working definitions for the clinical diagnosis of inborn errors of immunity. J. Allergy Clin. Immunol. Pract. 7, 1763\u20131770 (2019).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"54732_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","volume":"4","author":"FA Bonilla","year":"2016","unstructured":"Bonilla, F. A. et al. International Consensus Document (ICON): Common variable immunodeficiency disorders. J. Allergy Clin. Immunol. Pract. 4, 38\u201359 (2016).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"54732_CR19","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.3389\/fimmu.2018.02130","volume":"9","author":"R Ameratunga","year":"2018","unstructured":"Ameratunga, R. Assessing disease severity in Common Variable Immunodeficiency Disorders (CVID) and CVID-Like disorders. Front. Immunol. 9, 2130 (2018).","journal-title":"Front. Immunol."},{"key":"54732_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","volume":"170","author":"EaL Bateman","year":"2012","unstructured":"Bateman, Ea. L. et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin. Exp. Immunol. 170, 202\u2013211 (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"54732_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.18176\/jiaci.0231","volume":"28","author":"G Azizi","year":"2018","unstructured":"Azizi, G. et al. Circulating Helper T-Cell Subsets and Regulatory T Cells in Patients With Common Variable Immunodeficiency Without Known Monogenic Disease. J. Investig. Allergol. Clin. Immunol. 28, 172\u2013181 (2018).","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"54732_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2249.2012.04620.x","volume":"169","author":"RR Barbosa","year":"2012","unstructured":"Barbosa, R. R. et al. Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels. Clin. Exp. Immunol. 169, 263\u2013272 (2012).","journal-title":"Clin. Exp. Immunol."},{"key":"54732_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4049\/jimmunol.164.1.488","volume":"164","author":"R Cambronero","year":"2000","unstructured":"Cambronero, R., Sewell, W. A., North, M. E., Webster, A. D. & Farrant, J. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J. Immunol. 164, 488\u2013494 (2000).","journal-title":"J. Immunol."},{"key":"54732_CR24","doi-asserted-by":"publisher","first-page":"614086","DOI":"10.3389\/fimmu.2020.614086","volume":"11","author":"N Marcus","year":"2020","unstructured":"Marcus, N. et al. Minor clinical impact of COVID-19 pandemic on patients with primary immunodeficiency in Israel. Front. Immunol. 11, 614086 (2020).","journal-title":"Front. Immunol."},{"key":"54732_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/23744235.2021.1957144","volume":"53","author":"CH Drabe","year":"2021","unstructured":"Drabe, C. H. et al. Low morbidity in Danish patients with common variable immunodeficiency disorder infected with severe acute respiratory syndrome coronavirus 2. Infect. Dis. 53, 953\u2013958 (2021).","journal-title":"Infect. Dis."},{"key":"54732_CR26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jaip.2020.11.006","volume":"9","author":"B Cohen","year":"2021","unstructured":"Cohen, B. et al. COVID-19 infection in 10 common variable immunodeficiency patients in New York City. J. Allergy Clin. Immunol. Pract. 9, 504\u2013507.e1 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"54732_CR27","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","volume":"147","author":"AM Shields","year":"2021","unstructured":"Shields, A. M., Burns, S. O., Savic, S. & Richter, A. G. & UK PIN COVID-19 Consortium. COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience. J. Allergy Clin. Immunol. 147, 870\u2013875.e1 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"54732_CR28","doi-asserted-by":"publisher","first-page":"994253","DOI":"10.3389\/fimmu.2022.994253","volume":"13","author":"TL Katzenstein","year":"2022","unstructured":"Katzenstein, T. L. et al. Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort study. Front. Immunol. 13, 994253 (2022).","journal-title":"Front. Immunol."},{"key":"54732_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","volume":"21","author":"J-Y Zhang","year":"2020","unstructured":"Zhang, J.-Y. et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 21, 1107\u20131118 (2020).","journal-title":"Nat. Immunol."},{"key":"54732_CR30","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41422-020-0391-9","volume":"30","author":"K Yu","year":"2020","unstructured":"Yu, K. et al. Dysregulated adaptive immune response contributes to severe COVID-19. Cell Res. 30, 814\u2013816 (2020).","journal-title":"Cell Res."},{"key":"54732_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","volume":"6","author":"W Wen","year":"2020","unstructured":"Wen, W. et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 6, 31 (2020).","journal-title":"Cell Discov."},{"key":"54732_CR32","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904\u2013916 (2021).","journal-title":"Nat. Med."},{"key":"54732_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2021.12.040","volume":"185","author":"P Georg","year":"2022","unstructured":"Georg, P. et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell 185, 493\u2013512.e25 (2022).","journal-title":"Cell"},{"key":"54732_CR34","doi-asserted-by":"publisher","first-page":"109209","DOI":"10.1016\/j.clim.2022.109209","volume":"246","author":"WH Khoo","year":"2023","unstructured":"Khoo, W. H. et al. Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild\/asymptomatic COVID-19. Clin. Immunol. 246, 109209 (2023).","journal-title":"Clin. Immunol."},{"key":"54732_CR35","doi-asserted-by":"publisher","first-page":"108590","DOI":"10.1016\/j.celrep.2020.108590","volume":"34","author":"C Yao","year":"2021","unstructured":"Yao, C. et al. Cell-type-specific immune dysregulation in severely ill COVID-19 patients. Cell Rep. 34, 108590 (2021).","journal-title":"Cell Rep."},{"key":"54732_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr, C. et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111, 77\u201385 (2008).","journal-title":"Blood"},{"key":"54732_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000501457","volume":"180","author":"S Yesillik","year":"2019","unstructured":"Yesillik, S., Agrawal, S., Gollapudi, S. V. & Gupta, S. Phenotypic analysis of CD4+ Treg, CD8+ Treg, and Breg cells in adult common variable immunodeficiency patients. Int. Arch. Allergy Immunol. 180, 150\u2013158 (2019).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"54732_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2016.12.002","volume":"176","author":"S Arduini","year":"2017","unstructured":"Arduini, S., Dunne, J., Conlon, N., Feighery, C. & Doherty, D. G. Mucosal-associated invariant T cells are depleted and functionally altered in patients with common variable immunodeficiency. Clin. Immunol. 176, 23\u201330 (2017).","journal-title":"Clin. Immunol."},{"key":"54732_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.clim.2007.12.007","volume":"127","author":"PFK Yong","year":"2008","unstructured":"Yong, P. F. K. et al. Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clin. Immunol. 127, 34\u201342 (2008).","journal-title":"Clin. Immunol."},{"key":"54732_CR40","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).","journal-title":"Science"},{"key":"54732_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"54732_CR42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41577-020-00429-3","volume":"20","author":"JS Lee","year":"2020","unstructured":"Lee, J. S. & Shin, E.-C. The type I interferon response in COVID-19: implications for treatment. Nat. Rev. Immunol. 20, 585\u2013586 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"54732_CR43","doi-asserted-by":"publisher","first-page":"e2116730119","DOI":"10.1073\/pnas.2116730119","volume":"119","author":"MD Galbraith","year":"2022","unstructured":"Galbraith, M. D. et al. Specialized interferon action in COVID-19. Proc. Natl. Acad. Sci. USA. 119, e2116730119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"54732_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"54732_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05770-9","volume":"9","author":"N Giovannone","year":"2018","unstructured":"Giovannone, N. et al. Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans. Nat. Commun. 9, 3287 (2018).","journal-title":"Nat. Commun."},{"key":"54732_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05771-8","volume":"9","author":"A Cao","year":"2018","unstructured":"Cao, A. et al. Galectin-9 binds IgM-BCR to regulate B cell signaling. Nat. Commun. 9, 3288 (2018).","journal-title":"Nat. Commun."},{"key":"54732_CR47","doi-asserted-by":"publisher","first-page":"vbac016","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"P Badia-I-Mompel","year":"2022","unstructured":"Badia-I-Mompel, P. et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform. Adv. 2, vbac016 (2022).","journal-title":"Bioinform. Adv."},{"key":"54732_CR48","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1038\/emboj.2012.155","volume":"31","author":"R Revilla-I-Domingo","year":"2012","unstructured":"Revilla-I-Domingo, R. et al. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J. 31, 3130\u20133146 (2012).","journal-title":"EMBO J."},{"key":"54732_CR49","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1126\/science.abd2321","volume":"369","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. Structural basis of a shared antibody response to SARS-CoV-2. Science 369, 1119\u20131123 (2020).","journal-title":"Science"},{"key":"54732_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B Cells. Cell 182, 73\u201384.e16 (2020).","journal-title":"Cell"},{"key":"54732_CR51","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895\u20131913.e19 (2021).","journal-title":"Cell"},{"key":"54732_CR52","doi-asserted-by":"publisher","first-page":"eaai8153","DOI":"10.1126\/sciimmunol.aai8153","volume":"2","author":"D Lau","year":"2017","unstructured":"Lau, D. et al. Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation. Sci. Immunol. 2, eaai8153 (2017).","journal-title":"Sci. Immunol."},{"key":"54732_CR53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41590-023-01497-y","volume":"24","author":"Y Zurbuchen","year":"2023","unstructured":"Zurbuchen, Y. et al. Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2. Nat. Immunol. 24, 955\u2013965 (2023).","journal-title":"Nat. Immunol."},{"key":"54732_CR54","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","volume":"141","author":"S Unger","year":"2018","unstructured":"Unger, S. et al. The TH1 phenotype of follicular helper T cells indicates an IFN-\u03b3-associated immune dysregulation in patients with CD21low common variable immunodeficiency. J. Allergy Clin. Immunol. 141, 730\u2013740 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"54732_CR55","doi-asserted-by":"publisher","first-page":"104456","DOI":"10.1016\/j.phrs.2019.104456","volume":"149","author":"D Maseda","year":"2019","unstructured":"Maseda, D., Ricciotti, E. & Crofford, L. J. Prostaglandin regulation of T cell biology. Pharmacol. Res. 149, 104456 (2019).","journal-title":"Pharmacol. Res."},{"key":"54732_CR56","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.0803767","volume":"183","author":"P Thebault","year":"2009","unstructured":"Thebault, P. et al. The C-type lectin-like receptor CLEC-1, expressed by myeloid cells and endothelial cells, is up-regulated by immunoregulatory mediators and moderates T cell activation. J. Immunol. 183, 3099\u20133108 (2009).","journal-title":"J. Immunol."},{"key":"54732_CR57","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s10875-022-01291-9","volume":"42","author":"A Klocperk","year":"2022","unstructured":"Klocperk, A. et al. Distinct CD8 T cell populations with differential exhaustion profiles associate with secondary complications in common variable immunodeficiency. J. Clin. Immunol. 42, 1254\u20131269 (2022).","journal-title":"J. Clin. Immunol."},{"key":"54732_CR58","doi-asserted-by":"publisher","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","volume":"5","author":"L Kuri-Cervantes","year":"2020","unstructured":"Kuri-Cervantes, L. et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci. Immunol. 5, eabd7114 (2020).","journal-title":"Sci. Immunol."},{"key":"54732_CR59","doi-asserted-by":"publisher","first-page":"eabd6832","DOI":"10.1126\/sciimmunol.abd6832","volume":"5","author":"C Maucourant","year":"2020","unstructured":"Maucourant, C. et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci. Immunol. 5, eabd6832 (2020).","journal-title":"Sci. Immunol."},{"key":"54732_CR60","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.immuni.2021.09.002","volume":"54","author":"B Kr\u00e4mer","year":"2021","unstructured":"Kr\u00e4mer, B. et al. Early IFN-\u03b1 signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. Immunity 54, 2650\u20132669.e14 (2021).","journal-title":"Immunity"},{"key":"54732_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36\u201349 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"54732_CR62","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ajpath.2014.11.023","volume":"185","author":"S Ong","year":"2015","unstructured":"Ong, S. et al. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am. J. Pathol. 185, 847\u2013861 (2015).","journal-title":"Am. J. Pathol."},{"key":"54732_CR63","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jhep.2013.04.029","volume":"59","author":"A Gl\u00e4ssner","year":"2013","unstructured":"Gl\u00e4ssner, A. et al. Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV\/HCV patients. J. Hepatol. 59, 427\u2013433 (2013).","journal-title":"J. Hepatol."},{"key":"54732_CR64","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/biomedicines11051391","volume":"11","author":"M Yang","year":"2023","unstructured":"Yang, M., Vanderwert, E., Kimchi, E. T., Staveley-O\u2019Carroll, K. F. & Li, G. The important roles of natural killer cells in liver fibrosis. Biomedicines 11, 1391 (2023).","journal-title":"Biomedicines"},{"key":"54732_CR65","doi-asserted-by":"publisher","first-page":"834862","DOI":"10.3389\/fimmu.2022.834862","volume":"13","author":"D Brownlie","year":"2022","unstructured":"Brownlie, D. et al. Comparison of lung-homing receptor expression and activation profiles on NK cell and T cell subsets in COVID-19 and influenza. Front. Immunol. 13, 834862 (2022).","journal-title":"Front. Immunol."},{"key":"54732_CR66","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3389\/fimmu.2018.00781","volume":"9","author":"LE Carlin","year":"2018","unstructured":"Carlin, L. E., Hemann, E. A., Zacharias, Z. R., Heusel, J. W. & Legge, K. L. Natural killer cell recruitment to the lung during influenza a virus infection is dependent on CXCR3, CCR5, and Virus Exposure Dose. Front. Immunol. 9, 781 (2018).","journal-title":"Front. Immunol."},{"key":"54732_CR67","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1182\/blood.V99.7.2490","volume":"99","author":"S Deaglio","year":"2002","unstructured":"Deaglio, S. et al. Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells. Blood 99, 2490\u20132498 (2002).","journal-title":"Blood"},{"key":"54732_CR68","doi-asserted-by":"publisher","first-page":"17858","DOI":"10.1073\/pnas.0903474106","volume":"106","author":"N Stanietsky","year":"2009","unstructured":"Stanietsky, N. et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA. 106, 17858\u201317863 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"54732_CR69","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","volume":"119","author":"LC Ndhlovu","year":"2012","unstructured":"Ndhlovu, L. C. et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 119, 3734\u20133743 (2012).","journal-title":"Blood"},{"key":"54732_CR70","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1182\/blood-2011-06-360321","volume":"119","author":"MK Gleason","year":"2012","unstructured":"Gleason, M. K. et al. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 119, 3064\u20133072 (2012).","journal-title":"Blood"},{"key":"54732_CR71","doi-asserted-by":"publisher","first-page":"e2018587118","DOI":"10.1073\/pnas.2018587118","volume":"118","author":"E Kvedaraite","year":"2021","unstructured":"Kvedaraite, E. et al. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity. Proc. Natl. Acad. Sci. USA. 118, e2018587118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"54732_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24360-w","volume":"12","author":"L Vanderbeke","year":"2021","unstructured":"Vanderbeke, L. et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat. Commun. 12, 4117 (2021).","journal-title":"Nat. Commun."},{"key":"54732_CR73","doi-asserted-by":"publisher","first-page":"e154183","DOI":"10.1172\/jci.insight.154183","volume":"7","author":"E Brauns","year":"2022","unstructured":"Brauns, E. et al. Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19. JCI insight 7, e154183 (2022).","journal-title":"JCI insight"},{"key":"54732_CR74","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s10875-023-01504-9","volume":"43","author":"M Chan","year":"2023","unstructured":"Chan, M. et al. Persistent SARS-CoV-2 PCR positivity despite anti-viral treatment in immunodeficient patients. J. Clin. Immunol. 43, 1083\u20131092 (2023).","journal-title":"J. Clin. Immunol."},{"key":"54732_CR75","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","volume":"606","author":"E Sefik","year":"2022","unstructured":"Sefik, E. et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature 606, 585\u2013593 (2022).","journal-title":"Nature"},{"key":"54732_CR76","doi-asserted-by":"publisher","first-page":"e74893","DOI":"10.1371\/journal.pone.0074893","volume":"8","author":"J Park","year":"2013","unstructured":"Park, J. et al. Interferon signature in the blood in inflammatory common variable immune deficiency. PLoS One 8, e74893 (2013).","journal-title":"PLoS One"},{"key":"54732_CR77","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1084\/jem.20140039","volume":"211","author":"M Perreau","year":"2014","unstructured":"Perreau, M. et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J. Exp. Med. 211, 2033\u20132045 (2014).","journal-title":"J. Exp. Med."},{"key":"54732_CR78","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"54732_CR79","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jaci.2016.04.043","volume":"139","author":"B Keller","year":"2017","unstructured":"Keller, B. et al. Disturbed canonical nuclear factor of \u03ba light chain signaling in B cells of patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 139, 220\u2013231.e8 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"54732_CR80","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81798-5","volume":"87","author":"R F\u00f6rster","year":"1996","unstructured":"F\u00f6rster, R. et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037\u20131047 (1996).","journal-title":"Cell"},{"key":"54732_CR81","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/35018581","volume":"406","author":"KM Ansel","year":"2000","unstructured":"Ansel, K. M. et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309\u2013314 (2000).","journal-title":"Nature"},{"key":"54732_CR82","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ni1100","volume":"5","author":"CDC Allen","year":"2004","unstructured":"Allen, C. D. C. et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat. Immunol. 5, 943\u2013952 (2004).","journal-title":"Nat. Immunol."},{"key":"54732_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47024-8","volume":"9","author":"C Ackermann","year":"2019","unstructured":"Ackermann, C. et al. HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules. Sci. Rep. 9, 10624 (2019).","journal-title":"Sci. Rep."},{"key":"54732_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29450-x","volume":"13","author":"J Rodr\u00edguez-Ubreva","year":"2022","unstructured":"Rodr\u00edguez-Ubreva, J. et al. Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses. Nat. Commun. 13, 1779 (2022).","journal-title":"Nat. Commun."},{"key":"54732_CR85","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1365-2249.1997.tb08314.x","volume":"110","author":"V Thon","year":"1997","unstructured":"Thon, V. et al. Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients. Clin. Exp. Immunol. 110, 174\u2013181 (1997).","journal-title":"Clin. Exp. Immunol."},{"key":"54732_CR86","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1399-3038.1996.tb00129.x","volume":"7","author":"D Brugnoni","year":"1996","unstructured":"Brugnoni, D. et al. CD4+ cells from patients with Common Variable Immunodeficiency have a reduced ability of CD40 ligand membrane expression after in vitro stimulation. Pediatr. Allergy Immunol. 7, 176\u2013179 (1996).","journal-title":"Pediatr. Allergy Immunol."},{"key":"54732_CR87","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ebiom.2016.02.025","volume":"6","author":"M Ebbo","year":"2016","unstructured":"Ebbo, M. et al. Low circulating natural killer cell counts are associated with severe disease in patients with common variable immunodeficiency. EBioMedicine 6, 222\u2013230 (2016).","journal-title":"EBioMedicine"},{"key":"54732_CR88","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1182\/blood.V94.11.3864","volume":"94","author":"G Sconocchia","year":"1999","unstructured":"Sconocchia, G. et al. CD38 triggers cytotoxic responses in activated human natural killer cells. Blood 94, 3864\u20133871 (1999).","journal-title":"Blood"},{"key":"54732_CR89","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070\u20131076 (2020).","journal-title":"Nat. Med."},{"key":"54732_CR90","doi-asserted-by":"publisher","first-page":"580237","DOI":"10.3389\/fimmu.2020.580237","volume":"11","author":"M Li","year":"2020","unstructured":"Li, M. et al. Elevated exhaustion levels of NK and CD8+ T cells as indicators for progression and prognosis of COVID-19 disease. Front. Immunol. 11, 580237 (2020).","journal-title":"Front. Immunol."},{"key":"54732_CR91","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s42003-023-05684-3","volume":"6","author":"K Barry","year":"2023","unstructured":"Barry, K., Murphy, C. & Mansell, A. NLRP1- A CINDERELLA STORY: a perspective of recent advances in NLRP1 and the questions they raise. Commun. Biol. 6, 1274 (2023).","journal-title":"Commun. Biol."},{"key":"54732_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46322-8","volume":"15","author":"I Tsukalov","year":"2024","unstructured":"Tsukalov, I. et al. NF\u03baB and NLRP3\/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins. Nat. Commun. 15, 2100 (2024).","journal-title":"Nat. Commun."},{"key":"54732_CR93","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","volume":"606","author":"C Junqueira","year":"2022","unstructured":"Junqueira, C. et al. Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606, 576\u2013584 (2022).","journal-title":"Nature"},{"key":"54732_CR94","doi-asserted-by":"publisher","first-page":"17487","DOI":"10.1074\/jbc.RA119.010149","volume":"294","author":"S-D Ha","year":"2019","unstructured":"Ha, S.-D., Cho, W., DeKoter, R. P. & Kim, S. O. The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1\u03b2 eRNA and mRNA transcription in mouse melanoma and macrophage cell lines. J. Biol. Chem. 294, 17487\u201317500 (2019).","journal-title":"J. Biol. Chem."},{"key":"54732_CR95","doi-asserted-by":"publisher","first-page":"649572","DOI":"10.3389\/fimmu.2021.649572","volume":"12","author":"T Yashiro","year":"2021","unstructured":"Yashiro, T. et al. PU.1 and IRF8 modulate activation of NLRP3 inflammasome via regulating its expression in human macrophages. Front. Immunol. 12, 649572 (2021).","journal-title":"Front. Immunol."},{"key":"54732_CR96","doi-asserted-by":"publisher","first-page":"106685","DOI":"10.1016\/j.isci.2023.106685","volume":"26","author":"R Morita","year":"2023","unstructured":"Morita, R. et al. COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient. iScience 26, 106685 (2023).","journal-title":"iScience"},{"key":"54732_CR97","doi-asserted-by":"publisher","first-page":"53","DOI":"10.18176\/jiaci.0726","volume":"32","author":"M Speletas","year":"2021","unstructured":"Speletas, M. et al. B cells and COVID-19: Lessons from patients with Agammaglobulinemia and the study of functional B-cell polymorphisms. J. Investig. Allergol. Clin. Immunol. 32, 53\u201355 (2021).","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"54732_CR98","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","volume":"146","author":"I Quinti","year":"2020","unstructured":"Quinti, I. et al. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J. Allergy Clin. Immunol. 146, 211\u2013213.e4 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"54732_CR99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","volume":"38","author":"A Bousfiha","year":"2018","unstructured":"Bousfiha, A. et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J. Clin. Immunol. 38, 129\u2013143 (2018).","journal-title":"J. Clin. Immunol."},{"key":"54732_CR100","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","volume":"5","author":"R Ameratunga","year":"2014","unstructured":"Ameratunga, R. et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front. Immunol. 5, 415 (2014).","journal-title":"Front. Immunol."},{"key":"54732_CR101","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41592-020-0820-1","volume":"17","author":"H Heaton","year":"2020","unstructured":"Heaton, H. et al. Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes. Nat. Methods 17, 615\u2013620 (2020).","journal-title":"Nat. Methods"},{"key":"54732_CR102","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"54732_CR103","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"54732_CR104","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"54732_CR105","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"54732_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: An R-based toolkit for single-cell immune receptor analysis. F1000Res. 9, 47 (2020).","journal-title":"F1000Res."},{"key":"54732_CR107","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"54732_CR108","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Single-cell mRNA quantification and differential analysis with Census. Nat. Methods 14, 309\u2013315 (2017).","journal-title":"Nat. Methods"},{"key":"54732_CR109","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","volume":"22","author":"NK Bj\u00f6rkstr\u00f6m","year":"2022","unstructured":"Bj\u00f6rkstr\u00f6m, N. K., Strunz, B. & Ljunggren, H.-G. Natural killer cells in antiviral immunity. Nat. Rev. Immunol. 22, 112\u2013123 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"54732_CR110","doi-asserted-by":"publisher","unstructured":"Calvillo C. L. & Calafell-Segura J. BALLESTARLAB\/CVID-COVID. November-2024. https:\/\/doi.org\/10.5281\/zenodo.14046594 (2024).","DOI":"10.5281\/zenodo.14046594"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54732-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54732-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54732-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T11:02:40Z","timestamp":1732791760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54732-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54732"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54732-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2246352\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10344"}}